|
T43.8X2D Poisoning by other psychotropic drugs, intentional self-harm, subsequent encounter |
|
T43.8X3D Poisoning by other psychotropic drugs, assault, subsequent encounter |
|
T43.8X4D Poisoning by other psychotropic drugs, undetermined, subsequent encounter |
|
T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter |
|
T43.8X6D Underdosing of other psychotropic drugs, subsequent encounter |
|
T43.91XD Poisoning by unspecified psychotropic drug, accidental (unintentional), subsequent encounter |
|
T43.92XD Poisoning by unspecified psychotropic drug, intentional self-harm, subsequent encounter |
|
T43.93XD Poisoning by unspecified psychotropic drug, assault, subsequent encounter |
|
T43.94XD Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter |
|
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter |
|
T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter |
|
T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter |
|
T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter |
|
T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter |
|
T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter |
|
T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter |
|
T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter |
|
T44.1X1D Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter |
|
T44.1X2D Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter |
|
T44.1X3D Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter |
|
T44.1X4D Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter |
|
T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter |
|
T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter |
|
T44.2X1D Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter |
|
T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter |
|
T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter |
|
T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter |
|
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter |
|
T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter |
|
T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter |
|
T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter |
|
T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter |
|
T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter |
|
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
|
T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
|
T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
|
T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
|
T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
|
T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
|
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
|
T44.4X6D Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
|
T44.5X1D Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
|
T44.5X2D Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
|
T44.5X3D Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter |
|
T44.5X4D Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter |
|
T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter |
|
T44.5X6D Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter |
|
T44.6X1D Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
|
T44.6X2D Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
|
T44.6X3D Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter |
|
T44.6X4D Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter |
|
T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter |
|
T44.6X6D Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter |
|
T44.7X1D Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
|
T44.7X2D Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
|
T44.7X3D Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter |
|
T44.7X4D Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter |
|
T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter |
|
T44.7X6D Underdosing of beta-adrenoreceptor antagonists, subsequent encounter |
|
T44.8X1D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter |
|
T44.8X2D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter |
|
T44.8X3D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter |
|
T44.8X4D Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter |
|
T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
|
T44.8X6D Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
|
T44.901D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
|
T44.902D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
|
T44.903D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter |
|
T44.904D Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
|
T44.905D Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
|
T44.906D Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
|
T44.991D Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
|
T44.992D Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
|
T44.993D Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter |
|
T44.994D Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
|
T44.995D Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter |
|
T44.996D Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter |
|
T45.0X1D Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter |
|
T45.0X2D Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter |
|
T45.0X3D Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter |
|
T45.0X4D Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter |
|
T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter |
|
T45.0X6D Underdosing of antiallergic and antiemetic drugs, subsequent encounter |
|
T45.1X1D Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter |
|
T45.1X2D Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter |
|
T45.1X3D Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter |
|
T45.1X4D Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter |
|
T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter |
|
T45.1X6D Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter |
|
T45.2X1D Poisoning by vitamins, accidental (unintentional), subsequent encounter |
|
T45.2X2D Poisoning by vitamins, intentional self-harm, subsequent encounter |
|
T45.2X3D Poisoning by vitamins, assault, subsequent encounter |
|
T45.2X4D Poisoning by vitamins, undetermined, subsequent encounter |
|
T45.2X5D Adverse effect of vitamins, subsequent encounter |
|
T45.2X6D Underdosing of vitamins, subsequent encounter |
|
T45.3X1D Poisoning by enzymes, accidental (unintentional), subsequent encounter |
|
T45.3X2D Poisoning by enzymes, intentional self-harm, subsequent encounter |
|
T45.3X3D Poisoning by enzymes, assault, subsequent encounter |
|
T45.3X4D Poisoning by enzymes, undetermined, subsequent encounter |
|
T45.3X5D Adverse effect of enzymes, subsequent encounter |
